•
Dec 31, 2017

CRISPR Therapeutics Q4 2017 Earnings Report

Total Revenue
$32.3M
Previous year: $2.34M
+1279.1%
EPS
$0.00307
Previous year: $0.43
-99.3%
Gross Profit
$12.3M
Previous year: -$13.2M
-192.9%
Cash and Equivalents
$240M
Previous year: $316M
-24.0%
Free Cash Flow
-$15M
Previous year: -$53.1M
-71.7%
Total Assets
$271M
Previous year: $345M
-21.3%

CRISPR Therapeutics

CRISPR Therapeutics